£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Cell-Based Brain Tumor Therapeutics Outlook China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study examines the latent demand outlook for cell-based brain tumor therapeutics across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions, and Taiwan. The analysis provides potential industry earnings (P.I.E.) estimates across approximately 1,100 cities in China, offering detailed market penetration data for each major urban centre and its proportional share within its region. Researchers, pharmaceutical companies, healthcare investors, and policy makers will find actionable insights into regional market dynamics, growth opportunities, and therapeutic demand patterns across China's diverse healthcare landscape from 2023 through 2028.

Key Features

Covers latent demand outlook for cell-based brain tumor therapeutics across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions.

Provides potential industry earnings (P.I.E.) estimates for approximately 1,100 cities throughout China with regional market share analysis.

Offers market research data from 2023-2028 outlook period, enabling strategic planning for pharmaceutical and biotech stakeholders.

Includes detailed geographic breakdown of cell-based brain tumor therapeutics demand across major urban centres and regional divisions.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

2023-2028 Advanced Therapy Medicinal Products Outlook - China
92% match

2023-2028 Advanced Therapy Medicinal Products Outlook - China

£495.00 28 Sep 2026
2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China
92% match

2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
92% match

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Therapeutics CNS China Outlook
92% match

2023-2028 Orphan Diseases Therapeutics CNS China Outlook

£495.00 28 Sep 2026
2023-2028 Transmucosal Drug Delivery Outlook - China Market
91% match

2023-2028 Transmucosal Drug Delivery Outlook - China Market

£495.00 28 Sep 2026
2023-2028 Therapeutic Plasma Exchange Outlook - China
91% match

2023-2028 Therapeutic Plasma Exchange Outlook - China

£495.00 28 Sep 2026
2023-2028 Spinal Cord Trauma Corticosteroid Treatments Outlook China
91% match

2023-2028 Spinal Cord Trauma Corticosteroid Treatments Outlook China

£495.00 28 Sep 2026
2023-2028 Chemotherapy Nausea Drug Outlook - China Market Study
90% match

2023-2028 Chemotherapy Nausea Drug Outlook - China Market Study

£495.00 28 Sep 2026
2023-2028 Beta Interferon Therapeutics Outlook China
90% match

2023-2028 Beta Interferon Therapeutics Outlook China

£495.00 28 Sep 2026
2023-2028 Compact Advance Radiotherapy Systems Outlook - China
90% match

2023-2028 Compact Advance Radiotherapy Systems Outlook - China

£495.00 28 Sep 2026
2023-2028 Autism Spectrum Disorder Therapeutics Outlook China
90% match

2023-2028 Autism Spectrum Disorder Therapeutics Outlook China

£495.00 28 Sep 2026
Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028
90% match

Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028

£495.00 28 Sep 2026
2023-2028 Acute Agitation Aggression Treatments Outlook China
90% match

2023-2028 Acute Agitation Aggression Treatments Outlook China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India
90% match

The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India

£515.00 27 Sep 2026
2023-2028 Rheumatoid Arthritis Pharma Outlook China
90% match

2023-2028 Rheumatoid Arthritis Pharma Outlook China

£495.00 28 Sep 2026
2023-2028 Injectable Drug Delivery Devices Outlook China
89% match

2023-2028 Injectable Drug Delivery Devices Outlook China

£495.00 28 Sep 2026
2023-2028 Monoclonal Antibodies Market Outlook - China
89% match

2023-2028 Monoclonal Antibodies Market Outlook - China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States
89% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States

£520.00 27 Sep 2026
2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China
89% match

2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China

£495.00 28 Sep 2026
Bloodstream Infection Testing Outlook China 2023-2028
89% match

Bloodstream Infection Testing Outlook China 2023-2028

£495.00 28 Sep 2026
The 2023-2028 Outlook for Immune-Oncology Treatments in India
89% match

The 2023-2028 Outlook for Immune-Oncology Treatments in India

£515.00 27 Sep 2026
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
89% match

2023-2028 Nasal Drug Delivery Outlook for China - Market Research

£495.00 28 Sep 2026
2023-2028 Myelodysplastic Syndrome Drugs Market Outlook - China
89% match

2023-2028 Myelodysplastic Syndrome Drugs Market Outlook - China

£495.00 28 Sep 2026
2023-2028 Hypercalcemia Treatment Outlook for China
89% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026